PATENT CLAIM ANALYSIS

Application Number: 16153052
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["435", "440000"]

Abstract:
This invention relates to the use of CRISPR nucleic acids to screen for essential and non-essential genes and expendable genomic islands in bacteria, archaea, algae and/or yeast, to kill bacteria, archaea, algae and/or yeast, to identify the phenotype of a gene or genes, and/or to screen for reduced genome size and/or a gene deletion in bacteria, archaea, algae and/or yeast.

Claim (Index 20):
The method of  claim 11 , wherein the heterologous nucleic acid construct is comprised in a phage.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 97.0
- Lexical Diversity: 1.89189
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15167727', '15032985', '15160405', '15460962', '15507176']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.667748660713328
- 35 USC 102 Novelty (BERT): 0.6237922152632552
- Combined Prediction Score: 0.6633530161683208
- Mean Citation Score: 471.122638
- Max Citation Score: 734.0977
- Similarity Product: 474.13389124946

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test